Tonix Pharmaceuticals Inc. (TNXP) - שולי רווח נקי ממכירות

Tonix Pharmaceuticals (TNXP) develops treatments for viruses and CNS pathologies, where success depends on FDA verdicts. The depth of sales margins confirms this potential, and its current level is -420.40. Growth is expected from vaccines and fibromyalgia therapy. However, critical debt and dependence on final drug trials pose serious threats to the issuer's financial stability.
פילוחים אנליטיים של חברת Tonix Pharmaceuticals Inc. (TNXP)

Net profit margin determines the portion of profit remaining from every dollar of revenue after covering all operating and tax expenses. By analyzing the net margin, an investor assesses cost management efficiency, which is critical for Tonix Pharmaceuticals (TNXP) due to its total reliance on third-party contract manufacturers and the risks of rising external outsourcing costs during the creation of dosage forms.